Home > Products > CD3 & CD79B
> Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Fv-IgG) (CAT#: BSDG-070)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD3 IgG with similar domains from an anti-CD79B antibody via short peptide linkers, or vice versa. This BsAb can retarget T cells to tumor cells. It is designed for the research of Chronic lymphocytic leukemia (CLL); Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Fv-IgG) (BSDG-070). Click the button below to contact us or submit your feedback about this product.